China News Service, Wuxi, March 18th (Reporter Sun Quan) March 18th is "National Liver Love Day".
On the same day, Wuxi Fifth People's Hospital ("Wuxi Fifth Hospital") launched a large-scale public welfare clinic activity of "Scientific Screening, Protecting Liver", and launched the "Online Live Science Popularization + Offline Free Clinic Consultation + Free Early Liver Cancer Screening" Innovative popular science combination boxing to help citizens and patients take care of the "heart and liver baby" in all directions.
Wuxi Fifth Hospital is the earliest established third-level public infectious disease hospital in southern Jiangsu and the only public infectious disease hospital in Wuxi for the treatment of various infectious diseases. It has a history of more than 20 years and is a "liver cancer science education base" awarded by the Chinese Anti-Cancer Association. one.
The picture shows a blood test of patients participating in the free clinic.
Sun Quanshe
Qiu Yuanwang, deputy dean of Wuxi Fifth Hospital, said that for the public benefit consultation, the hospital specially invited Shanghai's top expert team through the "Taihu Talent Program". On the one hand, it is to provide the general public with more professional and authoritative knowledge.
On the other hand, it provides better free clinic services for liver disease patients suffering from intractable diseases.
"Whether it is hepatitis, liver cirrhosis, or liver cancer, there are basically no symptoms in the early stage. Patients often miss the best treatment period when they come to see a doctor. We hope that through the free consultation, people at high risk of liver disease can easily get some professional advice, especially It is to remind patients of the early symptoms that they usually ignore, so that they can be checked in time and treated early." Qiu Yuanwang said.
In the live science popularization session online, Chen Wei, director of the Interventional Department of Wuxi Fifth Hospital, and Bao Hao, head of Generic Health Technology, together brought a popular science lecture on "liver cancer is not terrible, early detection and early intervention".
In the lecture, Chen Wei suggested that patients with chronic hepatitis should be screened every six months, and patients with liver cirrhosis should be screened every three months.
Related propaganda posters are posted on the corridors of the hospital.
Sun Quanshe
"There are 70 million hepatitis B virus carriers and 7 million liver cirrhosis patients in China. They are all high-risk groups for liver cancer." Bao Hao said that although my country has made positive progress in the field of hepatitis B prevention and treatment, liver cancer prevention and treatment still has a long way to go.
Regarding cancer screening methods, Chen Wei introduced that clinically, alpha-fetoprotein and imaging tests are generally used to preliminarily judge liver tumors.
Now, in addition to traditional techniques, the emergence of new liquid biopsy techniques has greatly increased the detection rate of early liver cancer.
During the free clinic, experts from Shanghai visited the hospital with doctors from the fifth hospital.
Sun Quanshe
On the day of the free clinic, Wuxi Fifth Hospital also worked with Genetron Health to provide HCCscreenTM liver cancer early screening tests for hundreds of eligible patients with liver cirrhosis for free.
It is reported that HCCscreenTM is jointly developed by the National Cancer Center and Genetron Health. By testing a small amount of blood, liver cancer can be detected in the asymptomatic stage.
This technology was recognized by the U.S. FDA as a "breakthrough medical device" in 2020, and was included in the "Guidelines for Patients with Primary Liver Cancer of the Chinese Anti-Cancer Association" earlier this year, and it is clearly stated that this technology is better than traditional liver cancer early screening. Fetuin detection.
In November last year, HCCscreenTM was applied to the regional demonstration project of "Hepatic Cancer Early Screening and Comprehensive Prevention and Control" jointly initiated by the National Cancer Center, Huishan District People's Government in Wuxi City and Genetron Health.
In Wuxi, many patients with early liver cancer have benefited from this project.
(Finish)